A high-throughput drug screen reveals means to differentiate triple-negative breast cancer

Plasticity delineates cancer subtypes with more or less favourable outcomes. In breast cancer, the subtype triple-negative lacks expression of major differentiation markers, e.g., estrogen receptor α (ERα), and its high cellular plasticity results in greater aggressiveness and poorer prognosis than...

Descripción completa

Detalles Bibliográficos
Autores principales: Vulin, Milica, Jehanno, Charly, Sethi, Atul, Correia, Ana Luísa, Obradović, Milan M. S., Couto, Joana Pinto, Coissieux, Marie-May, Diepenbruck, Maren, Preca, Bogdan-Tiberius, Volkmann, Katrin, der Maur, Priska Auf, Schmidt, Alexander, Münst, Simone, Sauteur, Loïc, Kloc, Michal, Palafox, Marta, Britschgi, Adrian, Unterreiner, Vincent, Galuba, Olaf, Claerr, Isabelle, Lopez-Romero, Sandra, Galli, Giorgio G., Baeschlin, Daniel, Okamoto, Ryoko, Soysal, Savas D., Mechera, Robert, Weber, Walter P., Radimerski, Thomas, Bentires-Alj, Mohamed
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9507968/
https://www.ncbi.nlm.nih.gov/pubmed/36008466
http://dx.doi.org/10.1038/s41388-022-02429-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9507968/
https://www.ncbi.nlm.nih.gov/pubmed/36008466
http://dx.doi.org/10.1038/s41388-022-02429-0

Ejemplares similares